Francis, J., Zvada, S. P., Denti, P., Hatherill, M., Charalambous, S., Mungofa, S., . . . McIlleron, H. M. (2019). A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. Antimicrob Agents Chemother.
Chicago Style CitationFrancis, Jose, et al. "A Population Pharmacokinetic Analysis Shows That Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine." Antimicrob Agents Chemother 2019.
MLA CitationFrancis, Jose, et al. "A Population Pharmacokinetic Analysis Shows That Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine." Antimicrob Agents Chemother 2019.